The demand for pumps in the European pharmaceutical industry is expected to increase because of certain re-initiated projects in the recovering economies. Product types including centrifugal, peristaltic and lobe pumps will have a significant rise in their revenue shares in the total market triggered by competitive factors like total cost of ownership and energy efficiency.
New analysis from Frost & Sullivan (industrialautomation.frost.com), Strategic Analysis of Pumps Market in the European Pharmaceutical Industry, finds that the total market earned revenues of $85.4 million in 2009 and estimates this to reach $102.0 million in 2016.
"Since end users are more concerned about life-cycle cost and energy efficiency while purchasing a product, manufacturers are impelled to focus on reducing costs," says Frost & Sullivan Research Analyst Ram Ravi. "Additionally, volatile energy prices coupled with regulatory pressure focused on improving standards is expected to drive the demand for products with low lifecycle cost and high energy efficiency."
The pharmaceutical industry is anticipated to provide considerable growth opportunities in the long term driven by regulations, patents and investments in biotechnology. The need for industry participants in Eastern Europe to comply with EU standards will provide opportunities for replacing, upgrading or servicing their products. This is expected to be a short-term driver to this market.
However, customers prefer a one-stop-shop solution and focus on procuring complete integrated solutions as against stand-alone pumps. Pump suppliers are not equipped to provide such complete integrated solutions.
"Transformation into solution providers would require suppliers to extend their product portfolio and knowledge to other product types," explains Ravi. "This would require investment in training and knowledge transfer for new segments as well as in strategic partnership or acquisition."
Manufacturers should enhance their product portfolio with a particular interest on pumps with energy efficiency and low life cycle cost. Greater attention on offering innovative and strategic services is expected to result in short-term benefits.
"Intelligent pumps and services offer long-term growth potential," concludes Ravi. "Increasing awareness about the advantages of intelligent pumps enhances the probability of long-term success."
If you are interested in more information on this study, please send an email to Joanna Lewandowska, Corporate Communications, at joanna.lewandowska[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.
Strategic Analysis of Pumps Market in the European Pharmaceutical Industry is part of the Industrial Automation & Process Control Growth Partnership Services programme, which also includes research in the following markets: Strategic Analysis of the World Centrifugal Pumps Market, Strategic Analysis of the European Positive Displacement Pumps Market, Strategic Analysis of the Eastern European Pumps Market, and Strategic Analysis of the Pumps Market in the European Oil and Gas Industry. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.
Strategic Analysis of Pumps Market in the European Pharmaceutical Industry / M5A1-10
Twitter: twitter.com/frost_sullivan or facebook.com/FrostandSullivan